Calpain 3: a key regulator of the sarcomere?
暂无分享,去创建一个
[1] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[2] L. Peltonen,et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy , 2001, Neurology.
[3] J. Beckmann,et al. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. , 2001, American journal of physiology. Cell physiology.
[4] Chien-Chang Chen,et al. Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.
[5] H. Sorimachi,et al. Newly identified exons encoding novel variants of p94/calpain 3 are expressed ubiquitously and overlap the α‐glucosidase C gene , 2003, FEBS letters.
[6] P. Davies,et al. Ca2+ dependency of calpain 3 (p94) activation. , 2006, Biochemistry.
[7] M. Yamazaki,et al. Effects of Serum Deprivation on Expression of Proteolytic-Related Genes in Chick Myotube Cultures , 2005, Bioscience, biotechnology, and biochemistry.
[8] O. Pourquié,et al. Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. , 1998, Genomics.
[9] J. Beckmann,et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A , 1999, Nature Medicine.
[10] Wayne N Frankel,et al. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. , 2002, Genomics.
[11] P. Davies,et al. Active recombinant rat calpain II. Bacterially produced large and small subunits associate both in vivo and in vitro. , 1994, The Journal of biological chemistry.
[12] D. Balcerzak,et al. Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[13] I. Richard,et al. Force impairment in calpain 3–deficient mice is not correlated with mechanical disruption , 2003, Muscle & nerve.
[14] K Suzuki,et al. Functional Defects of a Muscle-specific Calpain, p94, Caused by Mutations Associated with Limb-Girdle Muscular Dystrophy Type 2A* , 1998, The Journal of Biological Chemistry.
[15] J. Beckmann,et al. Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice , 2000, The Journal of cell biology.
[16] C. Garcı́a-Martı́nez,et al. Calpain-3 gene expression is decreased during experimental cancer cachexia. , 2000, Biochimica et biophysica acta.
[17] M. Vorgerd,et al. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3 , 2005, Biological chemistry.
[18] H. Sorimachi,et al. Muscle-specific Calpain, p94, Responsible for Limb Girdle Muscular Dystrophy Type 2A, Associates with Connectin through IS2, a p94-specific Sequence (*) , 1995, The Journal of Biological Chemistry.
[19] J. Beckmann,et al. Expression and Functional Characteristics of Calpain 3 Isoforms Generated through Tissue-Specific Transcriptional and Posttranscriptional Events , 1999, Molecular and Cellular Biology.
[20] I. Richard,et al. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] S. Lecker,et al. Ubiquitin-protein ligases in muscle wasting. , 2005, The international journal of biochemistry & cell biology.
[22] Isabelle Richard,et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.
[23] J. Beckmann,et al. Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). , 1998, Brain : a journal of neurology.
[24] J. Beckmann,et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. , 1998, The American journal of pathology.
[25] R. Horowits. The physiological role of titin in striated muscle. , 1999, Reviews of physiology, biochemistry and pharmacology.
[26] M. Aoki,et al. Expression of tropism-related genes in regenerating skeletal muscle of rats treated with cyclosporin-A , 2005, Cell and Tissue Research.
[27] H. Kawasaki,et al. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. , 1998, The Biochemical journal.
[28] E. McNally,et al. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.
[29] Leena Peltonen,et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. , 2002, American journal of human genetics.
[30] M. Zatz,et al. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A , 2003, Journal of clinical pathology.
[31] J. Beckmann,et al. Chromosome 15-linked limb-girdle muscular dystrophy: Clinical phenotypes in Reunion Island and French metropolitan communities , 1996, Neuromuscular Disorders.
[32] N. Bourg,et al. Calpain 3 Is Activated through Autolysis within the Active Site and Lyses Sarcomeric and Sarcolemmal Components , 2003, Molecular and Cellular Biology.
[33] Z. Jia,et al. Crystal structure of calpain reveals the structural basis for Ca2+‐dependent protease activity and a novel mode of enzyme activation , 1999, The EMBO journal.
[34] D. MacArthur,et al. Limb–girdle muscular dystrophy: Diagnostic evaluation, frequency and clues to pathogenesis , 2008, Neuromuscular Disorders.
[35] T. Saido,et al. The behavior of calpain-generated N- and C-terminal fragments of talin in integrin-mediated signaling pathways. , 1999, Archives of biochemistry and biophysics.
[36] D. Attaix,et al. Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods. , 2005, The international journal of biochemistry & cell biology.
[37] J. Beckmann,et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. , 1999, Nature medicine.
[38] R. Campbell,et al. Homodimerization of calpain 3 penta-EF-hand domain. , 2005, The Biochemical journal.
[39] J. Beckmann,et al. Stable expression of calpain 3 from a muscle transgene in vivo: Immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] I. Richard,et al. Down-regulation of genes in the lysosomal and ubiquitin-proteasome proteolytic pathways in calpain-3-deficient muscle. , 2003, The international journal of biochemistry & cell biology.
[41] G. Lamb,et al. mu-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. , 2006, American journal of physiology. Cell physiology.
[42] H. Sorimachi,et al. A novel aspect of calpain activation , 1998, FEBS letters.
[43] E. Kudryashova,et al. Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain. , 2005, Human molecular genetics.
[44] J. Beckmann,et al. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. , 2001, Biophysical journal.
[45] P. Davies,et al. The protease core of the muscle‐specific calpain, p94, undergoes Ca2+‐dependent intramolecular autolysis , 2002, FEBS letters.
[46] I. Nishino,et al. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. , 2003, Journal of biochemistry.
[47] K. Bushby,et al. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach , 2001, Neuromuscular Disorders.
[48] H. Sorimachi,et al. A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.
[49] C. Angelini,et al. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. , 2003, The American journal of pathology.
[50] M. Yano,et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. , 1996, The Journal of clinical investigation.
[51] H. Kawasaki,et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. , 1993, The Journal of biological chemistry.
[52] M. Hermanová,et al. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome , 2004, Neuromuscular Disorders.
[53] E. Kudryashova,et al. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.
[54] J. Beckmann,et al. Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. , 2003, Muscle & nerve.
[55] J. Beckmann,et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.
[56] Z. Jia,et al. A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.
[57] J. Beckmann,et al. Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans , 2003 .
[58] C. Denis,et al. Molecular adaptations of neuromuscular disease‐associated proteins in response to eccentric exercise in human skeletal muscle , 2002, The Journal of physiology.
[59] N. Kanzawa,et al. A novel domain sequence of connectin localized at the I band of skeletal muscle sarcomeres: homology to neurofilament subunits. , 1993, Biochemical and biophysical research communications.
[60] H. Kawasaki,et al. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle. , 1989, The Journal of biological chemistry.
[61] R. Campbell,et al. Insertion Sequence 1 of Muscle-specific Calpain, p94, Acts as an Internal Propeptide* , 2004, Journal of Biological Chemistry.
[62] B. Yaspan,et al. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. , 2001, The Journal of biological chemistry.
[63] K. Suzuki,et al. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. , 1997, Archives of biochemistry and biophysics.
[64] E. Kudryashova,et al. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. , 2004, Human molecular genetics.
[65] K. Mathews,et al. Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.
[66] K. Bushby,et al. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display , 2005, European Journal of Human Genetics.
[67] C. Angelini,et al. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy , 2005, Neuromuscular Disorders.
[68] N. Forsberg,et al. Role of calpain in skeletal-muscle protein degradation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] I. Richard,et al. Calpains in muscle wasting. , 2005, The international journal of biochemistry & cell biology.
[70] I. Nonaka,et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy , 2001, Neuromuscular Disorders.